RVCL - RETINAL VASCULOPATHY CEREBRAL LEUKOENCEPHALOPATHY

Clinical trials for RVCL - RETINAL VASCULOPATHY CEREBRAL LEUKOENCEPHALOPATHY explained in plain language.

Never miss a new study

Get alerted when new RVCL - RETINAL VASCULOPATHY CEREBRAL LEUKOENCEPHALOPATHY trials appear

Sign up with your email to follow new studies for RVCL - RETINAL VASCULOPATHY CEREBRAL LEUKOENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Hope for rare fatal brain disease: drug trial shows promise

Disease control Completed

This study tested a drug called crizanlizumab in 18 adults with RVCL, a rare and fatal genetic condition that damages small blood vessels in the brain and eyes. The goal was to see if the drug could slow the growth of brain lesions seen on MRI scans. While not a cure, the trial a…

Matched conditions: RVCL - RETINAL VASCULOPATHY CEREBRAL LEUKOENCEPHALOPATHY

Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control

Last updated May 09, 2026 04:33 UTC

RVCL - RETINAL VASCULOPATHY CEREBRAL LEUKOENCEPHALOPATHY

Get alerted when new RVCL - RETINAL VASCULOPATHY CEREBRAL LEUKOENCEPHALOPATHY trials appear

Hope for rare fatal brain disease: drug trial shows promise